West Pharmaceutical Services Inc. (WST) Financial Statements (2024 and earlier)

Company Profile

Business Address 530 HERMAN O. WEST DRIVE
EXTON, PA 19341
State of Incorp. PA
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)
Annual | Quarterly

9/30/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments854894763616439337
Cash and cash equivalents854894763616439337
Receivables512507489385319288
Inventory, net of allowances, customer advances and progress billings435415378321236215
Inventory435415378321236215
Other current assets136103112526554
Total current assets:1,9361,9201,7421,3741,059894
Noncurrent Assets
Operating lease, right-of-use asset99104696870✕
Property, plant and equipment1,4131,1581,058943839822
Long-term investments and receivables21020520821519391
Long-term investments21020520821519391
Intangible assets, net (including goodwill)124126133142138126
Goodwill109107110111108106
Intangible assets, net (excluding goodwill)151823313020
Regulated entity, other noncurrent assets   1 11
Asset, held-in-trust     119
Deferred costs   16   
Deferred income tax assets26664916 ✕
Other noncurrent assets213839232521
Other undisclosed noncurrent assets  0113615
Total noncurrent assets:1,8931,6971,5721,4201,2831,085
TOTAL ASSETS:3,8303,6173,3142,7942,3411,979
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities259242261241193205
Interest and dividends payable✕✕✕  15 
Taxes payable✕✕✕26261310
Employee-related liabilities✕✕✕22265
Accounts payable242215232213157130
Accrued liabilities1727  6 
Deferred revenue     28✕
Debt1342442100
Other liabilities1551821631449177
Other undisclosed current liabilities12493126116202
Total current liabilities:672519594503342284
Noncurrent Liabilities
Long-term debt and lease obligation73207272313317196
Long-term debt, excluding current maturities73207209253255196
Liabilities, other than long-term debt204206113123107103
Deferred compensation liability, classified1919292313 
Deferred tax liabilities, net✕✕✕✕✕✕13
Deferred income tax liabilities1314510 ✕
Liability, pension and other postretirement and postemployment benefits302841585356
Other liabilities595238324134
Operating lease, liability8593636062✕
Other undisclosed noncurrent liabilities     3 
Total noncurrent liabilities:277413384436427299
Total liabilities:949932978939768583
Equity
Equity, attributable to parent2,8812,6852,3351,8551,5731,396
Common stock191919191919
Treasury stock, value(638)(371)(230)(168)(118)(104)
Additional paid in capital120232249267273282
Accumulated other comprehensive loss(144)(183)(160)(111)(150)(154)
Retained earnings3,5232,9882,4571,8471,5491,353
Total equity:2,8812,6852,3351,8551,5731,396
TOTAL LIABILITIES AND EQUITY:3,8303,6173,3142,7942,3411,979

Income Statement (P&L) ($ in millions)
Annual | Quarterly

9/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues2,9502,8872,8322,1471,8401,717
Cost of revenue
(Cost of Goods and Services Sold)		(1,821)(1,751)(1,656)(1,379)(1,234)(1,172)
Gross profit:1,1291,1361,176768606545
Operating expenses(440)(399)(418)(354)(317)(312)
Other operating income (expense), net 1(1)(1)55
Other undisclosed operating income (loss)(13)(4)(5)(7)32
Operating income:676734752407297240
Nonoperating income (expense)22(54)(3)(6)49
Investment income, nonoperating223(3)142
Gain (loss), foreign currency transaction, before tax(9)412  
Other nonoperating income (expense)3(51)41(0)7
Interest and debt expense(9)(8)(8)(8)(9)(8)
Other undisclosed income from continuing operations before equity method investments, income taxes9888  
Income from continuing operations before equity method investments, income taxes:698680749401292241
Income from equity method investments1821201798
Other undisclosed loss from continuing operations before income taxes      
Income from continuing operations before income taxes:716701769419301248
Income tax expense(122)(115)(107)(73)(59)(41)
Income from continuing operations:593586662346242207
Income before gain (loss) on sale of properties:✕✕✕662346242207
Net income:593586662346242207
Other undisclosed net income attributable to parent      
Net income available to common stockholders, diluted:593586662346242207

Comprehensive Income ($ in millions)
Annual | Quarterly

9/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net income:593586662346242207
Other comprehensive income (loss) (0)(23)(49)395(37)
Other undisclosed comprehensive loss      
Comprehensive income:593563613385246170
Other undisclosed comprehensive income, net of tax, attributable to parent39     
Comprehensive income, net of tax, attributable to parent:633563613385246170

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: